SCHEMBL13190989

SCHEMBL13190989

CC(C)OCC(O)COc1ccc(C(C)(C)c2ccc(OCC(O)COC(C)C)cc2)cc1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTT P42858 1/20 0.66
▸ HIF1A Q16665 1/20 0.66
▸ AR P10275 2/20 0.60
▸ KMT2A Q03164 3/20 0.51
▸ KDM4E B2RXH2 1/20 0.47
▸ ALDH1A1 P00352 1/20 0.47
▸ MAPT P10636 2/20 0.46
▸ LMNA P02545 2/20 0.46
▸ POLB P06746 2/20 0.46
▸ NPSR1 Q6W5P4 1/20 0.46
▸ NR2E1 Q9Y466 1/20 0.46
▸ GAA P10253 1/20 0.45
▸ MEN1 O00255 2/20 0.44
▸ CASR P41180 1/20 0.44
▸ HSD17B10 Q99714 1/20 0.43
▸ ADRB2 P07550 1/20 0.42
▸ ADRB1 P08588 1/20 0.42
▸ ADRB3 P13945 1/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ CYP2D6 P10635 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12267326 0.94 HTT (0.59) HTTHIF1AARKMT2AKDM4E
SCHEMBL19677468 0.94 HTT (0.59) HTTHIF1AARKMT2AKDM4E
SCHEMBL19193322 0.93 HTT (0.58) HTTHIF1AARKMT2AKDM4E
SCHEMBL22043340 0.93 HTT (0.58) HTTHIF1AARKMT2AKDM4E
SCHEMBL12267322 0.93 AR (0.72) HTTHIF1AARKMT2AKDM4E
SCHEMBL27378768 0.93 HTT (0.58) HTTHIF1AARKMT2AKDM4E
SCHEMBL22043203 0.92 HTT (0.57) HTTHIF1AARKMT2AKDM4E
SCHEMBL26461593 0.92 HTT (0.57) HTTHIF1AARKMT2AKDM4E
SCHEMBL19677445 0.90 HTT (0.56) HTTHIF1AARKMT2AKDM4E
SCHEMBL12267197 0.90 HTT (0.56) HTTHIF1AARKMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024098053-A1 POLYMER-NUCLEIC ACID NANOPARTICLES FOR GENE EDITING THE JOHNS HOPKINS UNIVERSITY (US) 2024-05-10 — — WO disclosed
WO-2023212057-A1 COMPOSITIONS OF KINETIC NANOPARTICLES CONTAINING NUCLEIC ACIDS, POLYCATIONS AND LIPIDS THE JOHNS HOPKINS UNIVERSITY (US) 2023-11-02 — — WO disclosed
WO-2023077150-A1 POLYMERS AND NANOPARTICLES FOR INTRAMUSCULAR NUCLEIC ACID DELIVERY THE JOHNS HOPKINS UNIVERSITY (US) 2023-05-04 — — WO disclosed
US-20140248263-A1 BISPHENOL COMPOUNDS AND METHODS FOR THEIR USE THE UNIVERSITY OF BRITISH COLUMBIA (CA) 2014-09-04 — — US disclosed
US-20140248263-A1 BISPHENOL COMPOUNDS AND METHODS FOR THEIR USE THE UNIVERSITY OF BRITISH COLUMBIA (CA) 2014-09-04 — — US disclosed
WO-2012139039-A2 BISPHENOL COMPOUNDS AND METHODS FOR THEIR USE BRITISH COLUMBIA CANCER AGENCY BRANCH (CA) 2012-10-11 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140248263-A1 BISPHENOL COMPOUNDS AND METHODS FOR THEIR USE AR, SHBG, ESRRA HTT 3685/4885HIF1A 2925/4885AR 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback